News for Cancer

Eight BRC projects get RCF funding

7 September 2020 · Listed under Cancer, Cardiovascular Medicine, Digital Health from Hospital to Home, Gene and Cell Therapy, Genomic Medicine, Imaging, Inflammation across Tissues, Metabolic Experimental Medicine, Molecular Diagnostics, Multimorbidity and Long-Term Conditions, Preventive Neurology, Surgical Innovation, Technology and Evaluation, Translational Data Science

Eight Oxford BRC proposals, many covering a number of themes, have been awarded NIHR Research Capability Funding (RCF) funding to take forward key areas of research. The selected projects that will be supported include: Developing a research centre devoted to urgent and acute careThe ... READ MORE

Home colorectal cancer tests could prioritise patients for referral

20 July 2020 · Listed under Cancer, Molecular Diagnostics

Non-invasive home-based tests that detect blood in patient stool samples offer an accurate and appropriate triaging method for GPs, according to University of Oxford researchers. The study, which is already informing a redesign of the colorectal cancer pathway at Oxford University Hospitals (OUH) ... READ MORE

Study sheds light on breast cancer risk after pre-invasive disease

28 May 2020 · Listed under Cancer, Translational Data Science

Women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast cancer and of death from breast cancer, compared with the general population, according to a study by Oxford researchers. DCIS is a disease where ... READ MORE

BRC cancer lead elected Royal Society Fellow

29 April 2020 · Listed under Cancer

The NIHR Oxford BRC’s Theme Lead for Cancer, Professor Xin Lu, has been elected as a Fellow of the Royal Society, in recognition of her contribution to cancer biology. As well as her role with the Oxford BRC, Xin Lu is Director of the Ludwig Institute for Cancer Research, Oxford Branch in the ... READ MORE

Seven new Senior Fellows named

2 April 2020 · Listed under Cancer, Gene and Cell Therapy, Other News, Preventive Neurology

The Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows, the second cohort of emerging research leaders to receive the accolade. The selection process was a coordinated effort by the Oxford BRC and its partners in the NIHR Oxford Health BRC, which focuses on ... READ MORE

Study suggests immune system plays key role in survival after pancreatic cancer surgery

12 February 2019 · Listed under Cancer, Inflammation across Tissues

Researchers in Oxford have found that an individual’s immune system – and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer. The study by the University of Oxford’s Department of Oncology and Kennedy ... READ MORE

Ultrasound and nanomedicine offer new hope for improving effects of cancer drugs

10 July 2018 · Listed under Cancer

In a breakthrough that allows the more precise targeting of drugs at cancers, a University of Oxford team has used ultrasound and lipid drug carriers to remotely trigger and enhance the delivery of a cancer drug in humans for the first time. The study was conducted by researchers from the ... READ MORE

Health minister visits Oxford BRC

30 May 2018 · Listed under Cancer, Genomic Medicine

The Health Minister, Lord O'Shaughnessy, visited the NIHR Oxford BRC on Wednesday 30 May to take a look at the ground-breaking research that is taking place in the fields of cancer and genomics. He was accompanied on the tour by Oxford BRC Director Prof Keith Channon and Head of Research ... READ MORE

New clinical trial aims to tackle bowel cancer

9 February 2018 · Listed under Cancer

Oxford University Hospitals has started a clinical trial which combines the use of immunotherapy with a protein-inhibiting drug for use with difficult-to-treat bowel cancer. Immunotherapy combined with checkpoint inhibitor drugs has been used successfully as treatment for several cancers, ... READ MORE

Top Oxford cancer specialist retires from clinical work

5 January 2018 · Listed under Cancer, Other News

One of Oxford’s leading breast cancer specialists is stepping down from clinical work, after working in the city for nearly 30 years, but will continue his research activities, which, with the support of NIHR Oxford BRC, have seen big advances in recent years. Prof Adrian Harris has been the ... READ MORE

Celsion announces TARDOX study combining ThermoDox and focused ultrasound to tackle cancers

21 November 2017 · Listed under Cancer

Celsion Corporation has launched a clinical trial, supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), to study the effectiveness of combining cancer drug ThermoDox with focused ultrasound to treat a range of tumours, including liver cancer The ... READ MORE

New bowel cancer test could save lives through early detection

21 September 2017 · Listed under Cancer

A new screening test, funded by NIHR Oxford BRC, is being hailed the most efficient way to indicate risk of colorectal cancer. First stage UK research, published today, shows that an advanced computer algorithm technology can successfully indicate levels of risk by analysing previous blood test ... READ MORE

Public Health Minister Visits Oxford Cancer Hospital ahead of World Cancer Day

4 February 2017 · Listed under Cancer, Genomic Medicine

Ahead of World Cancer Day on February, Public Health Minister Nicola Blackwood highlighted the importance of UK scientific research to beating cancer during a visit to the Churchill Hospital. The Public Health and Innovation Minister saw state-of-the-art clinical trials and facilities for new ... READ MORE

Monitoring prostate cancer “as effective as surgery”

14 September 2016 · Listed under Cancer

Active monitoring of prostate cancer is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind, funded by the National Institute for Health Research (NIHR). Results published in New England Journal of Medicine today, show that all three ... READ MORE

Discoveries offer hope for managing ovarian cancer

29 July 2016 · Listed under Cancer

Oxford University researchers have found a way to detect ovarian cancer early and identified an enzyme that is key in making ovarian cancer more deadly. Their results, published in two journals and co-funded by the NIHR Oxford Biomedical Research Centre, provide new research routes for scientists ... READ MORE

Rare mutations in bowel cancer may identify patients with a better prognosis

20 July 2016 · Listed under Cancer, Other News

An international collaboration between the University of Oxford and other European institutions has uncovered a correlation between a rare mutation in bowel cancers and a better prognosis, raising the possibility that patients with such tumours may not require chemotherapy after surgery. The ... READ MORE

Data debate video and podcast now online

23 June 2016 · Listed under Cancer, Digital Health from Hospital to Home, Life-saving Vaccines, Translational Data Science

A video of an hour-long debate on issues around mass sharing of patient data to support research and improve patient care can now be viewed online. “Good to share? Data, research, privacy and the NHS” was held as part of the NIHR Oxford Biomedical Research Centre’s Public Open Day – Celebrating ... READ MORE

Prostate cancer vaccine trial seeks volunteers

29 February 2016 · Listed under Cancer, Life-saving Vaccines

Oxford University scientists have started a clinical trial to test a new vaccine against prostate cancer and are looking for volunteers to take part. The first four participants have already received this experimental vaccine at the Churchill Hospital in Oxford, and the second trial site has just ... READ MORE

New clinical trial to tackle hard-to-treat leukaemia

2 December 2015 · Listed under Cancer, Gene and Cell Therapy

A new clinical trial at Oxford’s Churchill Hospital plans to study the safety of a new experimental drug to treat a form of leukaemia, called Acute Myeloid Leukaemia (AML). Acute myeloid leukaemia is the most common aggressive blood cancer and there are about 2,200 new cases in the UK each year. ... READ MORE

Precision medicine boost for Oxford

27 October 2015 · Listed under Cancer, Digital Health from Hospital to Home, Other News, Translational Data Science

Oxford is today named as a centre for excellence leading the drive to tailor more treatments to the needs of individual patients. A Precision Medicine Catapult centre will be established in Oxford bringing together business and research to develop new products and services. This project will ... READ MORE

15 Research Themes